Glucagon and glucose metabolism;Glucagon et glucorégulation

Annales d'Endocrinologie

Volumn 65, Issue 1, 2004, Pages 77-79

  Tappy, L ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; SOMATOMEDIN C;

CONFERENCE PAPER; DIABETES MELLITUS; EXERCISE; GLUCOSE METABOLISM; HORMONAL REGULATION; HUMAN; INFECTION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; STRESS;

EID: 2342616268     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(04)95635-1     Document Type: Conference Paper

References (19)

1. Boden G, Tappy L, Jadali F, et al. Role of glucagon in disposal of an amino acid load. Am J Physiol 1990; 259: E225-E232.
2. Cherrington AD. The metabolic actions of glucagon. In: Draznin B, Rizza R (eds), Clinical Research in Diabetes and Obesity. Humana Press, Totowa, N.J. 1997; 221-42.
3. Cherrington AD, Chiasson J-L, Liljenquist JE, Lacy WW, Park CR. Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp 1978; 43: 31-45.
4. Del Prato S, Castellino P, Simonson DC, DeFronzo RA. Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest 1987; 79: 547-56.
5. Dirlewanger M, Schneiter P, Paquot N, et al. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man. Clin Nutr 2000; 19: 29-34.
6. Gerich JE. Control of glycaemia. Baillieres Clin Endocrinol Metab 1993; 7: 551-86.
7. Jahoor F, Herndon DN, Wolfe RR. Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients. J Clin Invest 1986; 78: 807-14.
8. Jenssen T, Nurjhan N, Consoli A, Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. J Clin Invest 1990; 86: 489-97.
9. Lefèbvre PJ. Diabetes: abnormal secretion of glucagon. In: The Endocrine Pancreas, Ellis Samols (ed.), Raven Press, Ltd, New York, 1991; 191-205.
10. Liljenquist JE, Bomboy JD, Lewis SB, et al. Effects of glucagon on lipolysis and ketogenesis in normal and diabetic man. J Clin Invest 1974; 53: 190-97.
11. McGuinness OP, Lacy DB, Anderson J. Effect of acute glucagon removal on metabolic response to infection in conscious dog. Am J Physiol 1995; 268: E92-E99.
12. Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993; 42: 503-508.
13. Owen OE, Tappy L, Mozzoli MA, Smalley KJ. Acute starvation. In: The Metabolic and Molecular Basis of Acquired Disease. Baillière Tindall, London, 1990; 550-70.
14. Paquot N, Scheen AJ, Dirlewanger M, Lefèbvre PJ, Tappy L. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obesity Res 2002; 10: 129-34.
15. Paquot N, Tappy L, Schneiter P, Jéquier E. Effects of lactate infusion on basal and insulin-stimulated glucose metabolism in healthy subjects. Diabetologia 1993; 36, suppl. 1: A143.
16. Schneiter P, Gillet M, Chioléro R, et al. Mechanisms of post-prandial hyperglycemia in liver transplant recipients: comparison of liver transplant patients with kidney transplant patients and healthy controls. Diabetes Metab 2000; 26: 51-6.
17. Tappy L. Regulation of hepatic glucose production in healthy subjects and in NIDDM. Diabete Metab 1995; 21: 233-40.
18. Tounian P, Schneiter P, Henry S, Jéquier E, Tappy L. Effects of infused fructose on endogenous glucose production, gluconeogenesis and glycogen metabolism in healthy humans. Am J Physiol 1994; 267: E710-E717.
19. Wasserman DH, Jannifer A, Spalding D, et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 1989; 257: E-108-E117.